Gracell Biotechnologies Inc. - ADR

The momentum for this stock is not very good. Gracell Biotechnologies Inc. - ADR is not a good growth stock. Gracell Biotechnologies Inc. - ADR is not very popular among insiders. Tradey thinks it is not wise to invest in Gracell Biotechnologies Inc. - ADR.

News

Gracell Biotechnologies (NASDAQ:GRCL) Earns "Hold" Rating from Stifel Nicolaus

Ticker Report Stifel Nicolaus restated their hold rating on shares of Gracell Biotechnologies (NASDAQ:GRCL Free Report) in a report released on Thursday morning, Benzinga reports. Stifel Nicolaus currently...\n more…

Stifel Nicolaus Reiterates Hold Rating for Gracell Biotechnologies (NASDAQ:GRCL)

Zolmax Gracell Biotechnologies (NASDAQ:GRCL Get Free Report)s stock had its hold rating reaffirmed by stock analysts at Stifel Nicolaus in a report released on Thursday...\n more…

Gracell Biotechnologies Acquisition Completed

Globe Newswire SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ( Gracell or the Company , Nasdaq: GRCL), a global clinical-stage biopharmaceutical...\n more…

AstraZeneca Deal For Gracell Biotechnologies Closing Tomorrow (Includes CVR)

SeekingAlpha AstraZeneca Deal For Gracell Biotechnologies Closing Tomorrow (Includes CVR...\n more…

Gracell Biotechnologies Sees Unusually High Options Volume (NASDAQ:GRCL)

Zolmax Gracell Biotechnologies Inc. (NASDAQ:GRCL Get Free Report) saw unusually large options trading activity on Tuesday. Stock traders purchased 13,143 put options on the company. This is an...\n more…

Stock Traders Buy High Volume of Gracell Biotechnologies Put Options (NASDAQ:GRCL)

Ticker Report Gracell Biotechnologies Inc. (NASDAQ:GRCL Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock traders purchased 13,143 put options on the stock...\n more…